← SynDRA
IMEXON
SynDRA canonical compound SYN0004961 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | apoptosis stimulant | ribonucleotide reductase inhibitor |
Mechanisms of action (all sources)
- apoptosis stimulant
- ribonucleotide reductase inhibitor
Cross-references
Synonyms
- NSC-313425
- Amplimexon (TN)
- BM 06002
- 4-Amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one
- 4-Imino-1,3-diazabicyclo(3.1.0)hexan-2-one
- NSC 313425
- DTXCID9026895
- 4-Imino-1,3-diazabicyclo[3.1.0]hexan-2-one
- 4-Amino-1,3-diazabicyclo(3.1.0)hex-3-en-2-one
- NSC714597
- RefChem:790614
- 4-imino-1,3-diazabicyclo(3,1,0)-hexan-2-one
- 8F63U28T2V
- Amplimexon
- Imexonum
- MLS002702958
- NSC313425
- NCGC00181304-01
- Imexon (USAN/INN)
- 4-Imino-1,3-diazabicyclo-[3.1.0]hexan-2-one
- SCHEMBL154584
- GTPL8273
- orb1707185
- SCHEMBL3148692
- Amplimexon (proposed trade name)
- HMS3264B05
- Tox21_112779
- AKOS006273819
- AOP-990001
- CCG-213631
- NSC-714597
- NCGC00389454-01
- NCI60_002705
- SMR001566772
- BM 06 002
- CAS-59643-91-3
- NS00034209
- D08932
Look up IMEXON in the interactive SynDRA portal →